ML Strategies
Viewpoints
Filter by:
Alcohol Task Force Releases Final Report
January 23, 2018 | Advisory | By Julie Cox, Steven Baddour, Maxwell Fathy
The Task Force that Massachusetts Treasurer Deborah Goldberg commissioned to review the alcohol industry in the Commonwealth issued its final report on December 27, 2017.
Read more
Recreation Marijuana Industry Forges Ahead Amid Enforcement Uncertainty
January 22, 2018 | Alert | By Julie Cox, Caitlin Beresin
The Cannabis Control Commission (CCC) voted in late December to approve draft regulations establishing the framework for the recreational marijuana industry of Massachusetts.
Read more
Massachusetts Health Care Update: Senate Bill, Medication Switching, and Opioids
November 20, 2017 | Alert | By Julie Cox, Caitlin Beresin, Maxwell Fathy
Massachusetts policymakers continue to debate health care reform proposals with important implications for industry stakeholders.
Read more
Draft Regulations on Employer Health Care Assessment Released
November 13, 2017 | Alert | By Julie Cox, Maxwell Fathy
The Massachusetts Department of Unemployment Assistance has released draft regulations changing the existing Employer Medical Assistance Contribution (EMAC), creating a temporary supplemental contribution, and modifying the unemployment insurance rate schedule.
Read more
Massachusetts Lawmakers Hear Testimony on Non-Compete Legislation
November 6, 2017 | Alert | By Julie Cox, Maxwell Fathy, Sarah Engell
The Joint Committee on Labor and Workforce Development held a hearing on Tuesday, October 31 to receive testimony on the several bills introduced this session addressing the use of non-compete agreements in Massachusetts.
Read more
Massachusetts Senate Releases Comprehensive Health Care Legislation
October 19, 2017 | Advisory | By Brian Dempsey, Julie Cox, Steven Baddour, Daniel Connelly, Caitlin Beresin, Maxwell Fathy
On Tuesday, October 17, Massachusetts Senate leaders released comprehensive health care legislation containing a wide range of provisions significantly impacting industry stakeholders.
Read more
Managing the Energy Impacts of the Massachusetts Cannabis Industry
October 17, 2017 | Alert | By Caitlin Beresin, Julie Cox
State-by-state legalization of the medical and recreational use of marijuana is creating a new industry in the U.S. that has the potential to rival our largest businesses. However, the growth of this new industry comes at a cost.
Read more
Evolution of Repeal and Replace
September 22, 2017 | Advisory
The Republican evolution on health care over the course of 2017 has tested the resolve of the party’s years-long effort to repeal and replace the Affordable Care Act (ACA). The Republican goal of repeal and replace has reached a fever pitch, with days to go before we may come to a resolution on this nearly eight-year drive.
Read more
Fall Legislative Sessions Commence; Attorney General Certifies Ballot Questions
September 14, 2017 | Advisory | By Brian Dempsey, Julie Cox, Steven Baddour, Daniel Connelly, Caitlin Beresin, Maxwell Fathy
Massachusetts lawmakers have returned from summer recess and are preparing to tackle a robust legislative agenda this fall. Legislators will meet formally through the third Wednesday in November, at which point formal sessions will end until 2018.
Read more
Massachusetts Senators Hold Healthcare Roundtable Discussions
September 13, 2017 | Advisory | By Julie Cox, Olivia Castor, Sarah Engell
This past August, the Massachusetts Senate and the Millbank Memorial Fund Healthcare Working Group held three roundtable discussions geared towards finding solutions to rising healthcare costs and providing patients with more coordinated care.
Read more
Massachusetts Lawmakers Turn Attention to Cybersecurity
September 6, 2017 | Alert | By Brian Dempsey, Julie Cox, Maxwell Fathy
In the wake of growing concerns about data privacy and cyber threats, Massachusetts lawmakers are increasingly focused on evaluating and improving the state’s cybersecurity policies and information technology infrastructure.
Read more
Governor Baker Announces Mid-Year Budget Cuts, Draws Rebuke from Legislature
December 7, 2016 | Alert | By Julie Cox, Steven Baddour, Daniel Connelly, Maxwell Fathy
On Tuesday, December 6, Governor Charlie Baker, under his Section 9C authority, ordered $98 million in mid-year cuts from the $39.25 billion FY17 state budget. The administration has warned of budget imbalances for months and this action aims at aligning state revenues, which have lagged throughout the year, with projected spending.
Read more
Potential Paths to Deregulation in 2017
November 30, 2016 | Alert
Following the beginning of the 115th Congress (January 3) and President-elect Trump’s inauguration (January 20), the legislative and executive branches will have at their disposal a number of legal methods for following through on their deregulation pledges.
Read more
Recent Developments around Pharmaceutical Drug Spending in Massachusetts
November 14, 2016 | Alert | By Julie Cox, Steven Baddour, Daniel Connelly, Maxwell Fathy, Elena Horvit
Throughout the fall, policy makers in Massachusetts have sharpened their focus on the rise of pharmaceutical drug prices and their role in the growth of overall health care spending in the Commonwealth.
Read more
Flash: What the Election Means for Health Care
November 11, 2016 | Alert
There are a number of factors to consider that have broad implications beyond health care:
Read more
Massachusetts Outlook: The Remainder of 2016 and Beyond
October 4, 2016 | Alert | By Julie Cox, Steven Baddour, Daniel Connelly, Maxwell Fathy, Elena Horvit, Parnia Zahedi
After closing the book on the formal sessions in July, Massachusetts lawmakers have turned their attention to the November election. The Senate and House of Representatives convene in informal sessions for the remainder of the year and no controversial legislative matters are expected to pass during this time.
Read more
FDA Convenes Two-Day Public Hearing on Human Cell and Tissue Product Regulatory Paradigm
September 15, 2016 | Alert | By Joanne Hawana
As stakeholders and watchers of the expansive field of regenerative medicine likely are aware, earlier this year a study published in the peer-reviewed journal Cell Stem Cell reported on the growth of so-called stem cell clinics operating in the U.S.
Read more
Medicaid Managed Care Transitions’ Impact On Brain Injury Waiver Populations
September 9, 2016 | Alert | By Alexander Hecht
As of June 2015, 24 states utilize a traumatic or acquired brain injury waiver,1 as provided under section 1915(c) of the Social Security Act, which are designed to help individuals with traumatic brain injury (TBI) live in the community setting of their choice.
Read more
Massachusetts State Legislature Takes Action on Major Employment Reform as Legislative Session Ends
August 10, 2016 | Alert | By Julie Cox, Steven Baddour, Daniel Connelly, Parnia Zahedi, Hari Patel
In the final weeks before the end of the legislative session, the Massachusetts House and State both addressed major pieces of labor and employment legislation. However, although the legislature passed S.2119, an Act to establish pay equity, and S.2407, an Act relative to transgender anti-discrimination, much of the legislation that business leaders had been anticipating was left unfinished as lawmakers adjourned their formal session on the night of Sunday, July 31.
Read more
2015-2016 Massachusetts Legislative Session Ends
August 8, 2016 | Alert | By Julie Cox, Steven Baddour, Daniel Connelly, Parnia Zahedi
After a mad scramble to take action before their midnight deadline, Massachusetts lawmakers closed the 2015-2016 legislative session by passing five of the “Big Six” bills on their agenda. Beacon Hill saw a flurry of activity in the final weekend of July as lawmakers rushed to make up for months of little action.
Read more
Explore Other Viewpoints:
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- Energy & Sustainability
- Environmental Enforcement Defense
- Environmental Law
- FDA Regulatory
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology